A new twist on an old idea: A two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction

Jessica A. Hiemstra, Songtao Liu, Mark A. Ahlman, Karl H. Schuleri, Albert C. Lardo, Christopher P. Baines, Kevin C. Dellsperger, David A. Bluemke, Craig A. Emter

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We recently reported that mitochondrial dysfunction, characterized by increased mitochondrial permeability transition (MPT), was present in a translational swine model of heart failure with preserved ejection fraction (HFpEF). Cyclophilin D is a key component of the MPT pore, therefore, the purpose of this study was to test the efficacy of a novel cyclosporine (CsA) dosing scheme as a therapeutic alternative for HFpEF. Computed tomography (CT), two-dimensional speckle tracking two-dimensional speckle tracking (2DST), and invasive hemodynamics were used to evaluate cardiac function. CT imaging showed 14 weeks of CsA treatment caused eccentric myocardial remodeling (contrasting concentric remodeling in untreated HF animals) and elevated systemic pressures. 2DST detected left ventricular (LV) mechanics associated with systolic and diastolic dysfunction prior to the onset of significantly increased LV end diastolic pressure including: (1) decreased systolic apical rotation rate, longitudinal displacement, and longitudinal/radial/circumferential strain; (2) decreased early diastolic untwisting and longitudinal strain rate; and (3) increased late diastolic radial/circumferential mitral strain rate. LV mechanics associated with systolic and diastolic impairment was enhanced to a greater extent than seen in untreated HF animals following CsA treatment. In conclusion, CsA treatment accelerated the development of heart failure, including dilatory LV remodeling and impaired systolic and diastolic mechanics. Although our findings do not support CsA as a viable therapy for HFpEF, 2DST was effective in differentiating between progressive gradations of developing HF and detecting diastolic impairment prior to the development of overt diastolic dysfunction.

Original languageEnglish (US)
Article numbere00174
JournalPhysiological reports
Volume1
Issue number7
DOIs
StatePublished - Jan 1 2013

Fingerprint

Cyclosporine
Heart Failure
Mechanics
Tomography
Ventricular Remodeling
Therapeutics
Permeability
Swine
Hemodynamics
Blood Pressure
Pressure

Keywords

  • 2D speckle tracking
  • CT
  • Cyclosporine
  • Diastolic heart failure
  • HFpEF

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

A new twist on an old idea : A two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction. / Hiemstra, Jessica A.; Liu, Songtao; Ahlman, Mark A.; Schuleri, Karl H.; Lardo, Albert C.; Baines, Christopher P.; Dellsperger, Kevin C.; Bluemke, David A.; Emter, Craig A.

In: Physiological reports, Vol. 1, No. 7, e00174, 01.01.2013.

Research output: Contribution to journalArticle

Hiemstra, Jessica A. ; Liu, Songtao ; Ahlman, Mark A. ; Schuleri, Karl H. ; Lardo, Albert C. ; Baines, Christopher P. ; Dellsperger, Kevin C. ; Bluemke, David A. ; Emter, Craig A. / A new twist on an old idea : A two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction. In: Physiological reports. 2013 ; Vol. 1, No. 7.
@article{80fbbace89444230902edc1741befad0,
title = "A new twist on an old idea: A two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction",
abstract = "We recently reported that mitochondrial dysfunction, characterized by increased mitochondrial permeability transition (MPT), was present in a translational swine model of heart failure with preserved ejection fraction (HFpEF). Cyclophilin D is a key component of the MPT pore, therefore, the purpose of this study was to test the efficacy of a novel cyclosporine (CsA) dosing scheme as a therapeutic alternative for HFpEF. Computed tomography (CT), two-dimensional speckle tracking two-dimensional speckle tracking (2DST), and invasive hemodynamics were used to evaluate cardiac function. CT imaging showed 14 weeks of CsA treatment caused eccentric myocardial remodeling (contrasting concentric remodeling in untreated HF animals) and elevated systemic pressures. 2DST detected left ventricular (LV) mechanics associated with systolic and diastolic dysfunction prior to the onset of significantly increased LV end diastolic pressure including: (1) decreased systolic apical rotation rate, longitudinal displacement, and longitudinal/radial/circumferential strain; (2) decreased early diastolic untwisting and longitudinal strain rate; and (3) increased late diastolic radial/circumferential mitral strain rate. LV mechanics associated with systolic and diastolic impairment was enhanced to a greater extent than seen in untreated HF animals following CsA treatment. In conclusion, CsA treatment accelerated the development of heart failure, including dilatory LV remodeling and impaired systolic and diastolic mechanics. Although our findings do not support CsA as a viable therapy for HFpEF, 2DST was effective in differentiating between progressive gradations of developing HF and detecting diastolic impairment prior to the development of overt diastolic dysfunction.",
keywords = "2D speckle tracking, CT, Cyclosporine, Diastolic heart failure, HFpEF",
author = "Hiemstra, {Jessica A.} and Songtao Liu and Ahlman, {Mark A.} and Schuleri, {Karl H.} and Lardo, {Albert C.} and Baines, {Christopher P.} and Dellsperger, {Kevin C.} and Bluemke, {David A.} and Emter, {Craig A.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1002/phy2.174",
language = "English (US)",
volume = "1",
journal = "Physiological Reports",
issn = "2051-817X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - A new twist on an old idea

T2 - A two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction

AU - Hiemstra, Jessica A.

AU - Liu, Songtao

AU - Ahlman, Mark A.

AU - Schuleri, Karl H.

AU - Lardo, Albert C.

AU - Baines, Christopher P.

AU - Dellsperger, Kevin C.

AU - Bluemke, David A.

AU - Emter, Craig A.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - We recently reported that mitochondrial dysfunction, characterized by increased mitochondrial permeability transition (MPT), was present in a translational swine model of heart failure with preserved ejection fraction (HFpEF). Cyclophilin D is a key component of the MPT pore, therefore, the purpose of this study was to test the efficacy of a novel cyclosporine (CsA) dosing scheme as a therapeutic alternative for HFpEF. Computed tomography (CT), two-dimensional speckle tracking two-dimensional speckle tracking (2DST), and invasive hemodynamics were used to evaluate cardiac function. CT imaging showed 14 weeks of CsA treatment caused eccentric myocardial remodeling (contrasting concentric remodeling in untreated HF animals) and elevated systemic pressures. 2DST detected left ventricular (LV) mechanics associated with systolic and diastolic dysfunction prior to the onset of significantly increased LV end diastolic pressure including: (1) decreased systolic apical rotation rate, longitudinal displacement, and longitudinal/radial/circumferential strain; (2) decreased early diastolic untwisting and longitudinal strain rate; and (3) increased late diastolic radial/circumferential mitral strain rate. LV mechanics associated with systolic and diastolic impairment was enhanced to a greater extent than seen in untreated HF animals following CsA treatment. In conclusion, CsA treatment accelerated the development of heart failure, including dilatory LV remodeling and impaired systolic and diastolic mechanics. Although our findings do not support CsA as a viable therapy for HFpEF, 2DST was effective in differentiating between progressive gradations of developing HF and detecting diastolic impairment prior to the development of overt diastolic dysfunction.

AB - We recently reported that mitochondrial dysfunction, characterized by increased mitochondrial permeability transition (MPT), was present in a translational swine model of heart failure with preserved ejection fraction (HFpEF). Cyclophilin D is a key component of the MPT pore, therefore, the purpose of this study was to test the efficacy of a novel cyclosporine (CsA) dosing scheme as a therapeutic alternative for HFpEF. Computed tomography (CT), two-dimensional speckle tracking two-dimensional speckle tracking (2DST), and invasive hemodynamics were used to evaluate cardiac function. CT imaging showed 14 weeks of CsA treatment caused eccentric myocardial remodeling (contrasting concentric remodeling in untreated HF animals) and elevated systemic pressures. 2DST detected left ventricular (LV) mechanics associated with systolic and diastolic dysfunction prior to the onset of significantly increased LV end diastolic pressure including: (1) decreased systolic apical rotation rate, longitudinal displacement, and longitudinal/radial/circumferential strain; (2) decreased early diastolic untwisting and longitudinal strain rate; and (3) increased late diastolic radial/circumferential mitral strain rate. LV mechanics associated with systolic and diastolic impairment was enhanced to a greater extent than seen in untreated HF animals following CsA treatment. In conclusion, CsA treatment accelerated the development of heart failure, including dilatory LV remodeling and impaired systolic and diastolic mechanics. Although our findings do not support CsA as a viable therapy for HFpEF, 2DST was effective in differentiating between progressive gradations of developing HF and detecting diastolic impairment prior to the development of overt diastolic dysfunction.

KW - 2D speckle tracking

KW - CT

KW - Cyclosporine

KW - Diastolic heart failure

KW - HFpEF

UR - http://www.scopus.com/inward/record.url?scp=85008929610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008929610&partnerID=8YFLogxK

U2 - 10.1002/phy2.174

DO - 10.1002/phy2.174

M3 - Article

AN - SCOPUS:85008929610

VL - 1

JO - Physiological Reports

JF - Physiological Reports

SN - 2051-817X

IS - 7

M1 - e00174

ER -